Skip to main content
Pfizer COVID-19 vaccine appointments are available to our patients.
Sign up for Connect today
to schedule your vaccination.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Joint Clinical Trials Office
Explore this Website
Home
About
Toggle About menu options
News
JCTO Contacts
Careers
Our Clinical Trial Locations
Partner with the JCTO
Toggle Partner with the JCTO menu options
JCTO Fees
Open Clinical Trials
Investigators
Patients
Toggle Patients menu options
What is a Clinical Trial?
Frequently Asked Questions
Clinical Trial Questions to Ask Your Healthcare Team
Clinical Trials: Common Terms to Know
Understanding Clinical Trials and How They Work
Understanding Clinical Trials - In Spanish | En Español
Weill Cornell Medicine
Care
Discover
Teach
Home
About
Open Clinical Trials
Investigators
Patients
Home
Clinical Trials
Phase I/II Dose-Escalation Study of Fractionated and Multiple Dose 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date:
October 8, 2020
A Multi Center Phase I study of AIC100 in Relapsed and/or Refractory Advanced Thyroid Cancer and Anaplastic Thyroid Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date:
October 15, 2020
Single-Arm Phase II Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy with Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date:
January 13, 2021
A Pilot Study of Rimegepant in Moderate Plaque-type Psoriasis
Study Status:
Open to Enrollment
Primary Investigator:
Date:
January 15, 2021
Multimodal Neuroimaging in Traumatic Brain Injury
Study Status:
Open to Enrollment
Primary Investigator:
Date:
February 16, 2021
Daratumumab, Pomalidomide and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
Study Status:
Open to Enrollment
Primary Investigator:
Date:
February 24, 2021
Galectin GT-031: A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR-MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
Study Status:
Open to Enrollment
Primary Investigator:
Date:
February 26, 2021
VMO-01C: An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 in Subjects with Solid Tumors or Lymphoma
Study Status:
Open to Enrollment
Primary Investigator:
Date:
March 25, 2021
CSF Clearance in Sporadic Alzheimer’s Disease
Study Status:
Open to Enrollment
Primary Investigator:
Date:
March 25, 2021
The Effects of Iron on Oxidative Stress and Alzheimer’s Disease Biomarkers in Amyloid-Positive and Negative Elderly Individuals
Study Status:
Open to Enrollment
Primary Investigator:
Date:
March 25, 2021
« first
‹ previous
…
3
4
5
6
7
(current)
8
9
10
11
…
next ›
last »